NEXT CENTURY GROWTH INVESTORS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
NEXT CENTURY GROWTH INVESTORS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$4,716,000
-11.5%
41,322
-2.5%
0.59%
-17.6%
Q1 2019$5,328,000
-38.3%
42,385
-33.4%
0.71%
-42.0%
Q4 2018$8,631,000
-30.7%
63,608
+40.2%
1.23%
-15.0%
Q3 2018$12,450,000
+15.1%
45,358
-13.1%
1.44%
+4.6%
Q2 2018$10,816,000
+16.9%
52,213
-6.8%
1.38%
+11.8%
Q1 2018$9,255,000
-19.2%
56,039
-33.0%
1.24%
-13.2%
Q4 2017$11,448,000
-6.7%
83,612
-7.3%
1.42%
-3.4%
Q3 2017$12,274,000
-15.8%
90,152
-24.9%
1.47%
+5.4%
Q2 2017$14,572,000
-3.9%
120,038
-16.2%
1.40%
+8.8%
Q1 2017$15,156,000
-11.6%
143,202
-15.1%
1.28%
+22.3%
Q4 2016$17,140,000
+0.6%
168,688
+1.0%
1.05%
+34.3%
Q3 2016$17,045,000
-22.7%
167,014
-9.7%
0.78%
-23.9%
Q2 2016$22,051,000
-34.6%
184,884
-41.3%
1.03%
-35.3%
Q1 2016$33,718,000
+37.1%
314,860
+38.8%
1.59%
+49.7%
Q4 2015$24,599,000
+32.9%
226,892
+5.0%
1.06%
+38.1%
Q3 2015$18,506,000
+12.2%
216,076
+32.2%
0.77%
+35.4%
Q2 2015$16,497,000
-33.2%
163,505
-48.9%
0.57%
-34.6%
Q1 2015$24,693,000
+9.4%
320,231
-24.5%
0.87%
+6.6%
Q4 2014$22,578,000
-1.7%
424,327
-13.2%
0.81%
+0.2%
Q3 2014$22,959,000
+42.9%
488,609
+89.5%
0.81%
+57.7%
Q2 2014$16,061,000
-42.0%
257,849
-37.4%
0.52%
-37.4%
Q1 2014$27,708,000
+21.8%
411,956
-4.7%
0.82%
+30.6%
Q4 2013$22,749,000
+16.6%
432,499
-4.0%
0.63%
+12.5%
Q3 2013$19,507,000
+403.0%
450,717
+334.8%
0.56%
+351.6%
Q2 2013$3,878,000103,6550.12%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders